Severe mammarenaviral disease in guinea pigs effectively treated by an orally bioavailable fusion inhibitor, alone or in combination with favipiravir
Jonna B. Westover, Shibani Naik, Kevin W. Bailey, Luci Wandersee, Vidyasagar Reddy Gantla, Brady T. Hickerson, Ken McCormack, Greg Henkel, Brian B. Gowen
Topics & Concepts
FavipiravirVirologyJunin virusVirusEntry inhibitorViral envelopePharmacologyRabiesMedicineImmunologyViral entryViral replicationDiseaseAntigenLymphocytic choriomeningitisCoronavirus disease 2019 (COVID-19)PathologyInfectious disease (medical specialty)CD8Viral Infections and Outbreaks ResearchVirus-based gene therapy researchViral gastroenteritis research and epidemiology